Topical furosemide versus oral steroid in preoperative management of nasal polyposis

European Archives of Oto-Rhino-Laryngology

Volumn 263, Issue 8, 2006, Pages 767-771

  Kroflic, Bozidar ^a   Coer, Andrej ^b   Baudoin, Tomislav ^c   Kalogjera, Livije ^c  

^a General Hospital Celje   (Slovenia)

^b University Medical   (Slovenia)

^c SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Eosinophils; Furosemide; Histomorphometry; Nasal polyposis; Oral steroid

Indexed keywords

FUROSEMIDE; METHYLPREDNISOLONE; STEROID;

ADULT; AGED; ARTICLE; BIOPSY; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EDEMA; ENDOSCOPY; EOSINOPHIL; EOSINOPHIL COUNT; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; INTRAOPERATIVE PERIOD; MALE; MAST CELL; MORPHOMETRICS; NOSE POLYP; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RHINOSINUSITIS; SCORING SYSTEM; SMELLING; SYMPTOM; TREATMENT OUTCOME; TUMOR VOLUME;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; DIURETICS; FEMALE; FUROSEMIDE; GLUCOCORTICOIDS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHYLPREDNISOLONE; MIDDLE AGED; NASAL POLYPS; NOSE; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RECURRENCE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 33745952393     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-006-0061-7     Document Type: Article

References (24)

1. Bachert C, Gevaert P, Holtappels G, Cuvelier C, van Cauwenberge P (2000) Nasal polyposis: from cytokines to growth. Am J Rhinol 14(5):279-290
2. Bianco S, Vaghi A, Robuschi M, Refini RM, Pieroni MG, Sestrin P (1995) Steroid-sparing effect of inhaled lysine acetyl-salicylate and furosemide in high-dose beclomethasone-dependent asthma. J Allergy Clin Immunol 95:937-943
3. van Camp C, Clement PA (1994) Results of oral steroid treatment in nasal polyposis. Rhinology 32(1):5-9
4. Damm M, Jungehulsing M, Eckel HE, Schmidt M, Theissen P (1999) Effects of systemic steroid treatment in chronic polypoid rhinosinusitis evaluated with magnetic resonance imaging. Otolaryngol Head Neck Surg 120(4):517-523
5. Eberhart LH, Folz BJ, Wulf H, Geldner G (2003) Intravenous anesthesia provides optimal surgical conditions during microscopic and endoscopic sinus surgery. Laryngoscope 113(8):1369-1373
6. Echazarreta AL, Gomez FP, Ribas J, Achaval M, Barbera JA, Roca J, Chung KF, Rodriguez-Roisin R (1999) Effects of inhaled furosemide on platelet-activating factor challenge in mild asthma. Eur Respir J 14(3):616-621
7. Hamilos DL, Thawley SE, Kramper MA, Kamil A, Hamid QA (1999) Effect of intranasal fluticasone on cellular infiltration, endothelial adhesion molecule expression, and proinflammatory cytokine mRNA in nasal polyp disease. J Allergy Clin Immunol 103:79-87
8. Hinton AE, Buckley GJ (1990) Blood loss and haematological consequences related to nasal surgery. Clin Otolaryngol 15:253-256
9. Iwamoto LM, Fujiwara N, Nakamura KT, Wada RK (2004) Na-K-2Cl cotransporter inhibition impairs human lung cellular proliferation. Am J Physiol Lung Cell Mol Physiol 287(3):L510-L514
10. Jahnsen FL, Haye R, Gran E, Brandtzaeg P, Johansen FE (1999) Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia. J Immunol 163(3):1545-1551
11. Kountakis SE, Arango P, Bradley D, Wade ZK, Borish L (2004) Molecular and cellular staging for the severity of chronic rhinosinusitis. Laryngoscope 114(11):1895-1905
12. Lavallee SL, Iwamoto LM, Claybaugh JR, Dressel MV, Sato AK, Nakamura KT (1997) Furosemide-induced airway relaxation in guinea pigs: relation to Na-K-2Cl cotransporter function. Am J Physiol 273:L211-L216
13. Malm L (1997) Assessment and staging of nasal polyposis. Acta Otolaryngol 117(4):465-467
14. Niven AS, Argyros G (2003) Alternate treatments in asthma. Chest 123(4):1254-1265
15. Nonaka R, Nonaka M, Takanashi S, Jordana M, Dolovich J (1999) Eosinophil activation in the tissue: synthetic steroid, budesonide, effectively inhibits the survival of eosinophils isolated from peripheral blood but not nasal polyp tissues. J Clin Lab Immunol 51(1):39-53
16. Panet R, Eliash M, Pick M, Atlan H (2002) Na(+)/K(+)/Cl(-) cotransporter activates mitogen-activated protein kinase in fibroblasts and lymphocytes. J Cell Physiol 190(2):227-237
17. Passali D, Bernstein JM, Passali FM, Damiani V, Passali GC, Bellussi L (2003) Treatment of recurrent chronic hyperplastic sinusitis with nasal polyposis. Arch Otolaryngol Head Neck Surg 129(6):656-659
18. Prandota J (2002) Furosemide: progress in understanding its diuretic, anti-inflammatory, and bronchodilating mechanism of action, and use in the treatment of respiratory tract diseases. Am J Ther 9(4):317-328
19. Rudack C, Bachert C, Stoll W (1999) Effect of prednisolone on cytokine synthesis in nasal polyps. J Interferon Cytokine Res 19(9):1031-1035
20. Rudack C, Hauser U, Stoll W (1999) Effect of cytokines and fibroblasts on eosinophilic granulocyte survival in polyposis nasi. Laryngorhinootologie 78(7):378-381
21. Saunders MW, Wheatley AH, George SJ, Lai T, Birchall MA (1999) Do corticosteroids induce apoptosis in nasal polyp inflammatory cells? In vivo and in vitro studies. Laryngoscope 109(5):785-790
22. Watanabe K, Shirasaki H, Kanaizumi E, Himi T (2004) Effects of glucocorticoids on infiltrating cells and epithelial cells of nasal polyps. Ann Otol Rhinol Laryngol 113(6):465-473
23. Woodworth BA, Joseph K, Kaplan AP, Schlosser RJ (2004) Alterations in eotaxin, monocyte chemoattractant protein-4, interleukin-5, and interleukin-13 after systemic steroid treatment for nasal polyps. Otolaryngol Head Neck Surg 131(5):585-589
24. Yuengsrigul A, Chin TW, Nussbaum E (1999) Immunosuppressive and cytotoxic effects of furosemide on human peripheral blood mononuclear cells. Ann Allergy Asthma Immunol 83(6):559-566